Biotech News
Genenta Science Provides Update on CEO Ownership
ir.genenta.com2026-05-06 15:06 EST
MILAN and NEW YORK , Dec. 19, 2025 (GLOBE NEWSWIRE) -- Genenta Science (Nasdaq: GNTA), a clinical-stage gene-therapy company developing hematopoietic stem-cell-based immunotherapies for solid tumors, provides an update regarding the ownership position of its Chief Executive Officer and Co-Founder,